vs

Side-by-side financial comparison of Four Corners Property Trust, Inc. (FCPT) and Tarsus Pharmaceuticals, Inc. (TARS). Click either name above to swap in a different company.

Tarsus Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($151.7M vs $78.2M, roughly 1.9× Four Corners Property Trust, Inc.). Four Corners Property Trust, Inc. runs the higher net margin — 38.8% vs -5.5%, a 44.4% gap on every dollar of revenue. On growth, Tarsus Pharmaceuticals, Inc. posted the faster year-over-year revenue change (128.4% vs 9.4%). Over the past eight quarters, Tarsus Pharmaceuticals, Inc.'s revenue compounded faster (134.4% CAGR vs 8.4%).

Four Corners Property Trust, Inc. is a publicly traded real estate investment trust that acquires, owns, and manages a portfolio of high-quality net-leased commercial properties. Its assets are primarily restaurant and retail locations across the United States, with tenants largely operating in stable consumer-facing industry segments with proven operational performance.

Tarsus Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing innovative therapeutic candidates for unmet medical needs in ophthalmology, dermatology, and other specialty care areas. It operates primarily in the United States, with lead product candidates targeting common, underdiagnosed conditions including demodex blepharitis and rosacea.

FCPT vs TARS — Head-to-Head

Bigger by revenue
TARS
TARS
1.9× larger
TARS
$151.7M
$78.2M
FCPT
Growing faster (revenue YoY)
TARS
TARS
+119.0% gap
TARS
128.4%
9.4%
FCPT
Higher net margin
FCPT
FCPT
44.4% more per $
FCPT
38.8%
-5.5%
TARS
Faster 2-yr revenue CAGR
TARS
TARS
Annualised
TARS
134.4%
8.4%
FCPT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
FCPT
FCPT
TARS
TARS
Revenue
$78.2M
$151.7M
Net Profit
$30.4M
$-8.4M
Gross Margin
Operating Margin
55.3%
-5.3%
Net Margin
38.8%
-5.5%
Revenue YoY
9.4%
128.4%
Net Profit YoY
16.0%
63.8%
EPS (diluted)
$0.28
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FCPT
FCPT
TARS
TARS
Q1 26
$78.2M
Q4 25
$75.7M
$151.7M
Q3 25
$74.1M
$118.7M
Q2 25
$72.8M
$102.7M
Q1 25
$71.5M
$78.3M
Q4 24
$68.3M
$66.4M
Q3 24
$66.8M
$48.1M
Q2 24
$66.5M
$40.8M
Net Profit
FCPT
FCPT
TARS
TARS
Q1 26
$30.4M
Q4 25
$29.4M
$-8.4M
Q3 25
$28.8M
$-12.6M
Q2 25
$27.9M
$-20.3M
Q1 25
$26.2M
$-25.1M
Q4 24
$26.2M
$-23.1M
Q3 24
$25.6M
$-23.4M
Q2 24
$24.7M
$-33.3M
Operating Margin
FCPT
FCPT
TARS
TARS
Q1 26
55.3%
Q4 25
-5.3%
Q3 25
-12.2%
Q2 25
-21.6%
Q1 25
-33.5%
Q4 24
-36.8%
Q3 24
-52.3%
Q2 24
-81.6%
Net Margin
FCPT
FCPT
TARS
TARS
Q1 26
38.8%
Q4 25
38.9%
-5.5%
Q3 25
38.9%
-10.6%
Q2 25
38.3%
-19.8%
Q1 25
36.6%
-32.1%
Q4 24
38.3%
-34.8%
Q3 24
38.3%
-48.7%
Q2 24
37.1%
-81.6%
EPS (diluted)
FCPT
FCPT
TARS
TARS
Q1 26
$0.28
Q4 25
$0.27
$-0.17
Q3 25
$0.28
$-0.30
Q2 25
$0.28
$-0.48
Q1 25
$0.26
$-0.64
Q4 24
$0.27
$-0.57
Q3 24
$0.27
$-0.61
Q2 24
$0.27
$-0.88

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FCPT
FCPT
TARS
TARS
Cash + ST InvestmentsLiquidity on hand
$29.6M
$417.3M
Total DebtLower is stronger
$72.4M
Stockholders' EquityBook value
$1.7B
$343.4M
Total Assets
$3.0B
$562.2M
Debt / EquityLower = less leverage
0.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FCPT
FCPT
TARS
TARS
Q1 26
$29.6M
Q4 25
$12.1M
$417.3M
Q3 25
$6.7M
$401.8M
Q2 25
$6.0M
$381.1M
Q1 25
$22.3M
$407.9M
Q4 24
$4.1M
$291.4M
Q3 24
$44.5M
$317.0M
Q2 24
$17.2M
$323.6M
Total Debt
FCPT
FCPT
TARS
TARS
Q1 26
Q4 25
$1.2B
$72.4M
Q3 25
$1.2B
$72.3M
Q2 25
$1.2B
$72.1M
Q1 25
$1.2B
$72.0M
Q4 24
$1.1B
$71.8M
Q3 24
$1.1B
$71.7M
Q2 24
$1.2B
$71.6M
Stockholders' Equity
FCPT
FCPT
TARS
TARS
Q1 26
$1.7B
Q4 25
$1.6B
$343.4M
Q3 25
$1.5B
$335.1M
Q2 25
$1.5B
$332.6M
Q1 25
$1.4B
$342.5M
Q4 24
$1.5B
$224.5M
Q3 24
$1.4B
$237.5M
Q2 24
$1.3B
$252.2M
Total Assets
FCPT
FCPT
TARS
TARS
Q1 26
$3.0B
Q4 25
$2.9B
$562.2M
Q3 25
$2.8B
$534.6M
Q2 25
$2.8B
$495.0M
Q1 25
$2.7B
$500.8M
Q4 24
$2.7B
$377.0M
Q3 24
$2.6B
$376.3M
Q2 24
$2.5B
$376.8M
Debt / Equity
FCPT
FCPT
TARS
TARS
Q1 26
Q4 25
0.74×
0.21×
Q3 25
0.79×
0.22×
Q2 25
0.81×
0.22×
Q1 25
0.84×
0.21×
Q4 24
0.78×
0.32×
Q3 24
0.84×
0.30×
Q2 24
0.92×
0.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FCPT
FCPT
TARS
TARS
Operating Cash FlowLast quarter
$19.3M
Free Cash FlowOCF − Capex
$13.0M
FCF MarginFCF / Revenue
8.6%
Capex IntensityCapex / Revenue
4.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-22.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FCPT
FCPT
TARS
TARS
Q1 26
Q4 25
$192.3M
$19.3M
Q3 25
$48.9M
$18.3M
Q2 25
$43.8M
$-29.4M
Q1 25
$51.6M
$-20.7M
Q4 24
$144.1M
$-22.2M
Q3 24
$43.4M
$-8.7M
Q2 24
$39.7M
$-14.4M
Free Cash Flow
FCPT
FCPT
TARS
TARS
Q1 26
Q4 25
$13.0M
Q3 25
$16.3M
Q2 25
$-30.4M
Q1 25
$-21.2M
Q4 24
$-22.3M
Q3 24
$-8.9M
Q2 24
$-15.4M
FCF Margin
FCPT
FCPT
TARS
TARS
Q1 26
Q4 25
8.6%
Q3 25
13.8%
Q2 25
-29.6%
Q1 25
-27.1%
Q4 24
-33.5%
Q3 24
-18.6%
Q2 24
-37.8%
Capex Intensity
FCPT
FCPT
TARS
TARS
Q1 26
Q4 25
4.2%
Q3 25
1.6%
Q2 25
1.0%
Q1 25
0.8%
Q4 24
0.1%
Q3 24
0.6%
Q2 24
2.5%
Cash Conversion
FCPT
FCPT
TARS
TARS
Q1 26
Q4 25
6.53×
Q3 25
1.70×
Q2 25
1.57×
Q1 25
1.97×
Q4 24
5.51×
Q3 24
1.70×
Q2 24
1.61×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FCPT
FCPT

Rental revenue$69.8M89%
Restaurant revenue$8.4M11%

TARS
TARS

Segment breakdown not available.

Related Comparisons